MARCHF6

membrane associated ring-CH-type finger 6, the group of Membrane associated ring-CH-type fingers|Ring finger proteins

Basic information

Region (hg38): 5:10353695-10440388

Previous symbols: [ "MARCH6" ]

Links

ENSG00000145495NCBI:10299OMIM:613297HGNC:30550Uniprot:O60337AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • benign adult familial myoclonic epilepsy (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Epilepsy, familial adult myoclonic, 3ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic14978679; 20548044; 31664039

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MARCHF6 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MARCHF6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
25
clinvar
1
clinvar
26
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 25 1 0

Variants in MARCHF6

This is a list of pathogenic ClinVar variants found in the MARCHF6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-10356343-A-ATTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTATTTTAT Epilepsy, familial adult myoclonic, 3 Pathogenic (Jun 21, 2019)635281
5-10378790-G-C not specified Uncertain significance (May 10, 2024)3293299
5-10381823-C-T not specified Uncertain significance (Oct 13, 2023)3123500
5-10381881-G-A not specified Uncertain significance (Jan 16, 2024)3123505
5-10381933-T-AA Uncertain significance (Oct 01, 2024)3390292
5-10387006-A-G not specified Uncertain significance (Feb 21, 2024)3123506
5-10387042-C-T not specified Uncertain significance (Jan 09, 2024)3123507
5-10387053-G-A not specified Uncertain significance (May 08, 2023)2545014
5-10390352-G-C not specified Uncertain significance (Jul 30, 2023)2614624
5-10390376-C-T not specified Uncertain significance (Sep 27, 2024)3123508
5-10390390-G-A not specified Uncertain significance (Mar 25, 2024)3293300
5-10390405-G-C not specified Uncertain significance (Dec 17, 2021)3123509
5-10390423-A-G not specified Uncertain significance (Dec 12, 2023)3123510
5-10390444-A-G not specified Uncertain significance (Nov 11, 2024)3543304
5-10390463-C-T not specified Uncertain significance (Oct 20, 2024)3543314
5-10390469-C-T not specified Uncertain significance (Jun 18, 2021)3123511
5-10391557-A-G not specified Uncertain significance (Dec 10, 2024)3543309
5-10391569-A-G not specified Uncertain significance (Mar 19, 2024)3293298
5-10391639-A-G Epilepsy, familial adult myoclonic, 3 Uncertain significance (Mar 29, 2024)3065753
5-10391640-G-C not specified Uncertain significance (Dec 15, 2023)3123512
5-10391705-C-T not specified Uncertain significance (Jun 16, 2024)3293304
5-10400776-C-G Epilepsy, familial adult myoclonic, 3 Uncertain significance (Jul 23, 2021)1696602
5-10402062-C-A not specified Uncertain significance (Jul 26, 2021)3123513
5-10402095-A-G not specified Uncertain significance (Oct 29, 2024)3543307
5-10402098-G-A not specified Uncertain significance (May 01, 2024)3293301

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MARCHF6protein_codingprotein_codingENST00000274140 2686686
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.002.16e-7125740081257480.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.882635090.5170.00002775889
Missense in Polyphen44164.740.267081979
Synonymous0.6121761870.9430.00001051818
Loss of Function6.71460.20.06640.00000343638

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001030.000103
Ashkenazi Jewish0.00009920.0000992
East Asian0.00006010.0000544
Finnish0.000.00
European (Non-Finnish)0.00002670.0000264
Middle Eastern0.00006010.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase that promotes ubiquitination of DIO2, leading to its degradation. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. May cooperate with UBE2G1. {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:19651899}.;
Pathway
Protein processing in endoplasmic reticulum - Homo sapiens (human);ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Post-translational protein modification;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle (Consensus)

Recessive Scores

pRec
0.139

Intolerance Scores

loftool
0.207
rvis_EVS
-0.56
rvis_percentile_EVS
19.54

Haploinsufficiency Scores

pHI
0.278
hipred
Y
hipred_score
0.783
ghis
0.608

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.641

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
March6
Phenotype

Gene ontology

Biological process
proteasomal protein catabolic process;ubiquitin-dependent ERAD pathway;ERAD pathway;protein K48-linked ubiquitination;endoplasmic reticulum mannose trimming
Cellular component
ER ubiquitin ligase complex;endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum quality control compartment
Molecular function
ubiquitin-protein transferase activity;protein binding;zinc ion binding;enzyme binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity;ubiquitin-specific protease binding